$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the difference between dacomitinib and afatinib? What are the differences in treatment effects, side effects and indications between the two?
2026-02-01 22:25:32
Check Details
Price of brigatinib as a targeted drug and comparison of different versions
2026-02-01 22:25:32
Check Details
What are the adverse reactions of entrectinib? How to recognize and deal with these reactions?
2026-02-01 22:25:32
Check Details
Important information and precautions in the drug package insert of acalatinib
2026-02-01 22:25:32
Check Details
How is ibrutinib used? How do patients take medications correctly?
2026-02-01 22:25:32
Check Details
How much ruxolitinib tablets should you take per day? Does the dose need to be adjusted according to different conditions?
2026-02-01 22:25:32
Check Details
How does clofazimine prevent skin darkening? How should patients avoid this side effect while taking it?
2026-02-01 22:25:32
Check Details
How much does a course of treatment with gosatuzumab (Todavi) cost?
2026-02-01 22:25:32
Check Details
What are the possible side effects of evantuzumab? How can these side effects be managed to ensure treatment is safe?
2026-02-01 22:25:32
Check Details
Is ivonib a targeted drug? How to combine with other targeted drugs to improve efficacy?
2026-02-01 22:25:32
Check Details
What are the purchasing channels for mitotane? How to purchase drugs legally and ensure their quality?
2026-02-01 22:25:32
Check Details
How to store Pemetinib? What are the storage temperature and environmental requirements?
2026-02-01 22:25:32
Check Details
1
2
...
1393
1394
1395
1396
1397
1398
1399
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure